fbpx

REQUEST A CONSULTATION

Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.
search

COVID-19 Booster Shot Increases Protection Against Delta Variant Infection by 85%, Study Indicates

COVID-19 booster shot
A Sheba study suggests that higher levels of antibodies following a third dose of the Pfizer-BioNTech vaccine correlate with a reduced risk of COVID-19 infection.

According to a new Sheba Medical Center and Tel Aviv University study, published in the scientific journal Nature Immunology, the effectiveness of a third COVID-19 vaccine dose against PCR-confirmed infection, regardless of symptoms, is 85.6% higher compared to two doses.

In order to analyze the effectiveness of the third vaccine dose, researchers administered the jab to 12,290 healthcare workers who were not previously infected with COVID-19 and had already received the first and second vaccine doses.
Results indicate that out of the the12,290 participants, 407 (3.3%) tested positive for COVID-19 on a PCR test.

Data gathered as part of the study demonstrated that while the increase in antibodies is relatively small at around 170%, a 600% increase in neutralizing antibodies, which bind pathogens and prevent them from spreading infection, was recorded in comparison to the second vaccine dose.

The study also found that the higher levels of antibodies following a third dose of the Pfizer-BioNTech vaccine correlate with a reduced risk of COVID-19 infection.

Related
Sheba Shines in Forbes Israel's 2024 Best Doctors List
Forbes Israel's 2024 list includes 186 specialties and subspecialties, featuring 1,386 doctors from medical centers, institutions, and hospitals across the country. Sheba Medical Center leads…
Read More
Tristan with Dr. David Mishali
A Heart Like No Other: Tristan’s Ten Year Triumph with Sheba
It was ten years ago when a tiny heartbeat held a massive secret. Tristan, a lively little boy, was born with congenital heart disease and given only minutes to live. Thanks to Sheba, those few minutes turned into a decade of a vibrant life.
Read More
RWJBarnabas Health and ARC Innovation Collaborate on HealthSpace2030
Last week, ARC Innovation announced a new partnership with RWJBarnabas Health. They will act as an anchoring partner for its innovation hub, HealthSpace2030, a Jersey…
Read More